Grace Therapeutics, Inc. - Common Stock (NQ: GRCE )

2.490 +0.110 (+4.62%)

Streaming Delayed Price Updated: 3:59 PM EDT, Apr 25, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	10,544
Open	2.390
Bid (Size)	2.270 (1)
Ask (Size)	2.500 (1)
Prev. Close	2.380
Today's Range	2.320 - 2.490
52wk Range	1.750 - 4.965
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors

March 11, 2025

From Matinas BioPharma Holdings, Inc.

Via GlobeNewswire

Small-Cap Grace Therapeutics Touts Positive Data From Brain Hemorrhage Study

February 10, 2025

Grace Therapeutics' GTx-104 met its Phase 3 trial endpoint, showing clinical benefits over oral nimodipine. US NDA submission is expected in early 2025.

Via Benzinga

Performance

YTD	-37.75%	-37.75%
1 Month	+3.32%	+3.32%
3 Month	-36.15%	-36.15%
6 Month	-22.43%	-22.43%
1 Year	-22.43%	-22.43%

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.